1. Home
  2. Labeler Index
  3. Avera Mckennan Hospital
  4. 69189-2003
  5. NDC Package Code: 69189-2003-1 Ziprasidone

NDC Package 69189-2003-1 Ziprasidone

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
69189-2003-1
Package Description:
1 CAPSULE in 1 DOSE PACK
Product Code:
69189-2003
Proprietary Name:
Ziprasidone
Usage Information:
Ziprasidone is indicated for the treatment of schizophrenia, as monotherapy for the acute treatment of bipolar manic or mixed episodes, and as an adjunct to lithium or valproate for the maintenance treatment of bipolar disorder. When deciding among the alternative treatments available for the condition needing treatment, the prescriber should consider the finding of ziprasidone's greater capacity to prolong the QT/QTc interval compared to several other antipsychotic drugs [see Warnings and Precautions (5.2)]. Prolongation of the QTc interval is associated in some other drugs with the ability to cause torsade de pointes-type arrhythmia, a potentially fatal polymorphic ventricular tachycardia, and sudden death. In many cases this would lead to the conclusion that other drugs should be tried first. Whether ziprasidone will cause torsade de pointes or increase the rate of sudden death is not yet known [see Warnings and Precautions (5.2)].
11-Digit NDC Billing Format:
69189200301
NDC to RxNorm Crosswalk:
  • RxCUI: 313776 - ziprasidone HCl 40 MG Oral Capsule
  • RxCUI: 313776 - ziprasidone 40 MG Oral Capsule
  • RxCUI: 313776 - ziprasidone (as ziprasidone hydrochloride monohydrate) 40 MG Oral Capsule
    • Labeler Name:
    Avera Mckennan Hospital
    Sample Package:
    No
    Start Marketing Date:
    02-09-2016
    Listing Expiration Date:
    12-31-2018
    Exclude Flag:
    I
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 69189-2003-1?

    The NDC Packaged Code 69189-2003-1 is assigned to a package of 1 capsule in 1 dose pack of Ziprasidone, labeled by Avera Mckennan Hospital. The product's dosage form is and is administered via form.

    Is NDC 69189-2003 included in the NDC Directory?

    No, Ziprasidone with product code 69189-2003 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Avera Mckennan Hospital on February 09, 2016 and its listing in the NDC Directory is set to expire on December 31, 2018 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 69189-2003-1?

    The 11-digit format is 69189200301. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-169189-2003-15-4-269189-2003-01